
    
      Subject will be randomized into either ASP1941 before meal or ASP1941 after meal groups.
      Subjects will undergo a screening period before entering the long-term treatment. Dosage may
      be increased during the treatment period if subjects fulfill increasing criteria and the
      investigators adjudicate that no impact for subjects safety.
    
  